Cell Reports (Dec 2023)

Chronic chromosome instability induced by Plk1 results in immune suppression in breast cancer

  • Sridhar Kandala,
  • Maria Ramos,
  • Lena Voith von Voithenberg,
  • Alberto Diaz-Jimenez,
  • Sara Chocarro,
  • Johanna Keding,
  • Benedikt Brors,
  • Charles D. Imbusch,
  • Rocio Sotillo

Journal volume & issue
Vol. 42, no. 12
p. 113266

Abstract

Read online

Summary: Chromosome instability (CIN) contributes to resistance to therapies and tumor evolution. Although natural killer (NK) cells can eliminate cells with complex karyotypes, high-CIN human tumors have an immunosuppressive phenotype. To understand which CIN-associated molecular features alter immune recognition during tumor evolution, we overexpress Polo-like kinase 1 (Plk1) in a Her2+ breast cancer model. These high-CIN tumors activate a senescence-associated secretory phenotype (SASP), upregulate PD-L1 and CD206, and induce non-cell-autonomous nuclear factor κB (NF-κβ) signaling, facilitating immune evasion. Single-cell RNA sequencing from pre-neoplastic mammary glands unveiled the presence of Arg1+ macrophages, NK cells with reduced effector functions, and increased resting regulatory T cell infiltration. We further show that high PLK1-expressing human breast tumors display gene expression patterns associated with SASP, NF-κβ signaling, and immune suppression. These findings underscore the need to understand the immune landscape in CIN tumors to identify more effective therapies, potentially combining immune checkpoint or NF-κβ inhibitors with current treatments.

Keywords